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A synchrotron-based infrared microspectroscopy
study on the cellular response induced by gold
nanoparticles combined with X-ray irradiations
on F98 and U87-MG glioma cell lines
I. Martínez-Rovira, *a O. Seksek b,c and I. Yousef a
The inclusion of nanoparticles (NP) in radiotherapy has been shown to increase the damaging eﬀect on
tumor cells. However, the mechanisms of action of NP combined with radiotherapy, and the inﬂuence of
NP parameters and cell type on their radiosensitization capability at molecular and cellular levels still
remain unclear. Gold NP (AuNP) have become particularly popular due to their multiple advantages.
Within this context, our research work aimed to study the biochemical radiosensitization capacity of F98
and U87-MG glioma cell lines to 1.9 nm AuNP combined with X-ray irradiation. For this purpose, synchro-
tron-based infrared microspectroscopy (SR-FTIRM) was used as a powerful tool for biochemical compo-
sition and treatment response assessment of cells at a single-cell level. SR-FTIRM data, supported by
multivariate analysis, revealed clear AuNP-induced changes in the DNA, protein and lipid spectral regions.
The AuNP-related biochemical alterations appear prior to the irradiation, which gave us a ﬁrst indication
on the AuNP radiosensitization action. Biochemical modiﬁcations induced by the AuNP in the presence of
radiotherapy irradiations include enhanced conformational changes in the protein secondary structures,
variations in the intensity and position in the phosphodiester bands, and changes in the CH2 and CH3
stretching modes. These changes are better manifested at 24 hours post-irradiation time. SR-FTIRM
results showed a clear heterogeneity in the biochemical cell response, probably due to the distinct cell–
NP interactions and thus, to diﬀerent DNA damage and cell death processes.
1. Introduction
The radiosensitization potential of nanoparticles (NP) has
been previously reported in many biological studies (in vitro
and in vivo) in the past years (see, for instance ref. 1–5). Typical
radiosensitizers include metallic high-atomic number (Z)
materials that can augment the eﬀectiveness of radiotherapy
by inducing dose enhancement eﬀects specifically in the
tumor site. This leads to an increase in the therapeutic index.
The use of NP over the conventional contrast agents resulted
in a larger NP accumulation in the tumor due to the enhanced
permeability and retention (EPR) eﬀects.6 In addition, previous
studies reported that toxicity is highly reduced when using
very small NP (<5 nm).7
Among all types of NP, gold (Z = 79) nanoparticles (AuNP)
are particularly attractive since they are inert, highly biocompa-
tible, relatively easy to synthesize and functionalise, and they
have an increased cross section for photoelectric photon
absorption (specially for low X-ray energies).1,4,5,8,9 The latter
enhances the secondary electron production (short-range
photoelectrons and Auger electrons) and the local dose depo-
sition near the NP.10 At the same time, these electrons can
further increase the generation of reactive oxygen species
(ROS) and electron emission from nearby NP. Besides the pure
physical eﬀects, the presence of NP itself can also increase the
ROS production, and thus, the cellular damage.4,11
However, the radiosensitization mechanisms at molecular
and cellular levels still remain unclear. Results from the pre-
vious biological studies indicated that radiosensitization
eﬀects might be driven by biological mechanisms induced by
the NP rather than by physical (dose enhancement) eﬀects.
These mechanisms include oxidative stress, DNA damage
induction, cell cycle eﬀects and potential interference with cell
communication.12–16 This, along with the influence of many
other parameters like NP size, shape and coating, which at the
same time influence the NP distribution inside the cells, as
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well as the distinct cellular responses, largely complicates
research on radiosensitization eﬀects of NP.4
Fourier transform infrared microspectroscopy (FTIRM) can
shed some light on the mechanisms involved in the radiosen-
sitization eﬀects of NP. FTIRM is a non-destructive
vibrational technique for the analysis of biological samples.17
IR active molecular bonds of the main cell biomolecules
change the dipole moment as a result of the vibration that
occurs when infrared light is absorbed. The mid infrared
spectral region is the most important for studying biological
specimens since it includes the so-called ‘fingerprint region’
and the ‘lipids region’, which provides nucleic acid, protein,
lipid, carbohydrate composition and/or conformational
changes. This information enables the assessment of
cell functionality, cell division, diﬀerentiation, growth and
metabolism.17–21
Within this context, the objective of this study is to use syn-
chrotron-based FTIRM (SR-FTIRM) to disentangle radiosensiti-
zation eﬀects of gold NP (1.9 nm AuroVist™)22 in glioma cells.
Despite the current treatment options, high grade glioma has
poor prognosis in humans and thus, patient outcome could
benefit from the enhanced therapeutic index of combined
RT-NP modalities. Gaining new insights into the radiosensiti-
zation eﬀects of AuNP in glioma cells is essential to progress
on the development of NP-based therapeutics. In this work, we
present SR-FTIRM data on F98 and U87-MG glioma cell lines
to assess distinct cellular responses as a function of the cell
type. The highly brilliant infrared source used in SR-FTIRM
provided high spatial resolution and high quality information
required for the single-cell analysis of our work. To the best of
our knowledge, this is the first study that evaluates cell radio-
sensitization to AuNP by using SR-FTIRM.
2. Materials and methods
2.1. Cell culture: F98 and U87-MG
The response of the two glioma cell lines, F98 (rat, ATCC®
CRL-2397) and U87-MG (human, ATCC® HTB-14), was studied.
The F98 glioma rat cell line simulates the behavior of glioblas-
toma tumors due to its highly invasive pattern of growth
within the brain and low immunogenicity; it is commonly
used to evaluate the eﬀectiveness of several therapeutic
agents.23 The U87-MG human tumor model presents a non-
diﬀusely infiltrative growth pattern and it is one of the most
widely used cell lines, especially for anti-angiogenic therapy
studies.24
Both cell lines were purchased from LGC Standards
(Molsheim, France). They were maintained and passaged in a
high glucose (4.5 g L−1) Gibco™ DMEM medium (Life
Technologies SAS, Courtaboeuf, France) supplemented with
1 mM GlutaMAX™, 1 mM sodium pyruvate, 10% fetal calf
serum and 1% penicillin-streptomycin (10 000 U each), at
37 °C and 5% CO2. On the day prior to the treatments, 10
5
cells per well were seeded in 6-well plates and incubated
overnight.
2.2. Gold nanoparticles
Gold NP (1.9 nm AuroVist™) were purchased from
Nanoprobes (Yaphank, NY, USA). The potential of these NP
has been proved in previous biological studies.1,4,25,26
A stock solution was extemporaneously prepared by mixing
the AuNP (40 mg of gold) with 1 mL ultrapure water (Millipore
Direct Q8). After rapid dissolution, the solution was filtered
through a 0.2 μm centrifugal filter at 15 000g for 8 minutes
and kept at 4 °C. For cell treatment, the AuNP solution was
diluted in fresh supplemented cell medium at a final concen-
tration of 12 μM (500 μg mL−1).25 The cells were then incu-
bated at 37 °C and 5% CO2 for 24 hours.
25 Before the
irradiation protocol, the AuNP-containing medium was dis-
carded and replaced by 3 mL of fresh medium.
2.3. X-ray irradiation
Kilovoltage irradiations were performed at the Curie Institute
(Orsay, France) with an X-ray unit (XRAD 320, Cegelec). The
mean energy of this X-ray generator is 90 keV and the dose rate
is 1.1 Gy min−1. Each well plate was irradiated separately at 5,
10 and 20 Gy, respectively, for both cell lines, with and without
AuNP. Two non-irradiated wells (0 Gy, without and with AuNP)
were kept for controls. Just after irradiation, the medium was
replaced by fresh medium.
2.4. SR-FTIRM sample preparation
For SR-FTIRM measurements, samples had to undergo a
specific preparation protocol, i.e. cell fixation and deposition
on infrared transparent calcium fluoride (CaF2) cover
glasses.21,27 The cells were fixed at two post-irradiation times:
after the irradiation (T0h) to evaluate immediate treatment-
induced eﬀects, and after 24 hours (T24h) to assess the cellular
response from the treatment.
For both fixation times (T0h and T24h), the medium was
removed and kept in order to collect floating cells. Then,
100 μL of 0.05% trypsin–EDTA solution was added into each
well and incubated for 5 min. After cell detachment, the
medium with floating cells was added back to the trypsinized
cells, and 500 μL of fresh supplemented medium was added.
The cell suspension was then centrifuged at 1500 rpm for
5 min at 4 °C. The cellular pellet was rinsed with PBS, and
resuspended in 10% formalin neutral buﬀered solution
(Sigma-Aldrich). After 1 hour at room temperature, the
samples were centrifuged at 1500 rpm for 5 min and the pellet
was washed 3 times in Millipore water. The final cell suspen-
sions in water were kept at 4 °C until cytospinned down onto
0.5 mm thick infrared transparent CaF2 slides using a
Cytospin 4 centrifuge (ThermoFisher; 700 rpm for 5 min).
Dried cells were then analyzed by SR-FTIRM.
2.5. SR-FTIRM at ALBA Synchrotron
SR-FTIRM experiments were performed at the infrared beam-
line MIRAS of the ALBA-CELLS synchrotron light source using
the Hyperion 3000 microscope coupled to a Vertex 70 spectro-
meter (Bruker Optik GmbH, Germany). The measurements
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were performed in the transmission mode of operation of the
FTIR microscope. This microscope is operating with a 36×
Schwarzschild magnification objective (NA = 0.65) coupled to a
36× magnification condenser. The microscope is furnished
with a liquid nitrogen cooled 50 μm mercury cadmium tellur-
ide (MCT) detector. Around 70–100 cells were randomly col-
lected from each sample condition. Single point maps of indi-
vidual cells were collected in the 3800–900 cm−1 mid infrared
range at 4 cm−1 spectral resolution with 256 co-added scans
per spectrum. All spectra were obtained using a single
masking aperture size of 8 μm × 8 μm. Reference or back-
ground spectra were collected under the same acquisition
parameters of the sample. In particular, measurement in an
empty region on the CaF2 slides (without cells) was repeated
every 10 cell measurements, in order to take into account the
diﬀerences under the ambient conditions along the measure-
ments. The final cell absorbance spectrum was obtained by
subtracting the reference spectrum from the raw cell spectra.
The subtraction was done directly (automatically) using OPUS
7.5 software (Bruker Optik GmbH, Germany).
2.6. SR-FTIRM data analysis
Diﬀerences in the spectral features were evaluated by Principal
Component Analysis (PCA) using Unscrambler X (CAMO
Software AS, Norway). PCA was performed on vector normal-
ized second derivative spectra (Savitzky–Golay algorithm; 3rd
polynomial order). Vector normalization and PCA were separ-
ately applied in the 3100–2800 and 1800–1000 cm−1 spectral
regions.
Raw spectra were corrected following the rubber band
method (32 baseline points) using OPUS 7.5 (Bruker Optik
GmbH, Germany) in order to assess the area under several
spectral bands reported hereafter and represented in Fig. 1.
• Methyl asymmetric stretching: 2980–2945 cm−1 (CH3).
• Methylene asymmetric stretching: 2945–2900 cm−1 (CH2).
• Amide I: 1710–1598 cm−1 (AI).
• Amide II: 1590–1483 cm−1 (AII).
• Phosphate I: 1270–1186 cm−1 (PhI).
• Phosphate II: 1146–1004 cm−1 (PhII).
The total area under the spectra (except the
2800–1800 cm−1 region) was associated with the total cell
biomass (Cell) following previous studies.28,29 Violin plots
showing the probability density of the data for PhI/AII, PhII/
AII, AI/AII and CH2/CH3 ratios were generated, since these
ratios have been reported to provide valuable information on
cell response after treatments.28,30,31
2.7. Microphotography
F98 and U87-MG cells were seeded in a 35 mm polystyrene
Petri dishes using the same NP concentration and NP incu-
bation time as for SR-FTIRM measurements. After treatment,
the cells were washed in fresh medium and microscopy image
acquisition was performed using a 10× Nikon water-immersion
DIC objective placed on an Eclipse 80i Nikon microscope
(Scop Pro, Marolles-en-Hurepoix, France), which is equipped
with a Zyla 5.5 MPX Andor SCMOS cooled camera (Scop Pro,
France) and MetaMorph acquisition software (Molecular
Devices, Sunnyvale, CA).
2.8. Cell viability assay
Metabolic activity was evaluated using the resazurin–resorufin
cytotoxicity assay.32,33 Briefly, after irradiation treatment, the
cells were harvested in each well of the 6-well plate by using
the usual trypsin-EDTA procedure. The cells were counted and
100 μL of 105 cells per mL were seeded in 96-well microplates
and incubated for 24 hours at 37 °C. After 24 hours, the
medium was discarded and replaced by fresh medium contain-
ing 30 μg mL−1 of resazurin (from a filtered 1.2 mg mL−1 stock
solution in PBS). The cells were incubated for 3 hours at 37 °C,
and the fluorescence intensity measurement of each well was
performed using a Fluoroskan Ascent FL microplate reader
(Thermo Fisher Scientific, Illkirch, France) at 530 and 590 nm
for excitation and emission, respectively. The percentage of the
metabolic activity of the cell populations was evaluated as the
Fig. 1 F98 (left) and U87-MG (right) glioma cells: averaged absorbance spectra for controls and treated cells, in the presence (‘+NP’) and absence
(‘−NP’) of nanoparticles at two post-irradiation ﬁxation times (0 h and 24 h) irradiated with a dose of 20 Gy. The limits of the band/regions described
in section 2.6 are shown. For clarity, the diﬀerent averaged absorbance spectra have been shifted along the absorbance axis.
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ratio of the fluorescence intensity after treatment to the
control fluorescence intensity.
3. Results and discussion
Microphotography images for the qualitative assessment of
intracellular NP localization are shown in section 3.1. Then,
the results of SR-FTIRM analysis and cell viability assays are
presented for both cell lines (F98 and U87-MG) and several
irradiation doses (from 0 to 20 Gy) in the presence (+NP) and
absence (−NP) of AuNP and two post-irradiation fixation times
(T0h and T24h). SR-FTIRM details on the biochemical eﬀects
induced by the AuNP without (0 Gy) and with radiation are
presented in sections 3.2 and 3.3, respectively. The results of
cell viability assays are reported in section 3.4.
3.1. Microphotography for intracellular NP localization
assessment
Fig. 2 shows the bright field micrographs of F98 and U87-MG
cells, respectively, with and without AuNP. While both cell
lines show diﬀerent morphologies (F98 is elongated and U87-
MG is flatter and more spread on the cell support), nuclei can
be easily distinguished as well as cell boundaries. After AuNP
treatment and washing with fresh medium, free NP or NP
aggregates can still be clearly seen in the cell surroundings
(black dots). An unambiguous punctuated pattern inside the
cell cytoplasm can also reproducibly be shown, especially in
perinuclear areas. This strongly suggests an internalization
process.
Whether this process is active (endocytosis) or passive (per-
meation) could not be addressed by this microscopy experi-
ment. However, it has been shown elsewhere and on diﬀerent
cell types that the majority of 1.9 nm particles are endo-
cytosed.25 While on F98 cells, the size of the dots was quite the
same inside and outside of the cells, on U87-MG cells, the size
of the black dots seems to indicate that the AuNP are aggre-
gated. This might occur due to the intrinsic diﬀerences
between the endocytosis processes in both cell lines.
3.2. Biochemical eﬀects induced by the AuNP without
irradiation (0 Gy)
Fig. 3 and 4 show the PCA scores and the corresponding
loading plots on second derivative spectra for both F98 and
U87-MG cell lines, respectively. PCA allows the reduction of
the dimensionality of features in order to assess the simi-
larities and diﬀerences between spectra. In the PCA score plot,
each single point represents a cell spectrum. Loading plots
express the influence of the variables that are responsible for
each principal component as a function of the wavenumber.
PCA analysis was performed separately in the fingerprint
(1800–1000 cm−1) and lipid (3100–2800 cm−1) regions.
For the F98 glioma cell line, and prior to the radiotherapy
irradiation (0 Gy), the PC1–PC2 plot in the fingerprint region
shows a clear separation between NP-treated groups and the
control group (−NP), mostly along PC-1, which explains 73%
of the variance. PC-1 shows more variance for the NP-treated
groups. Fingerprint modifications are already observed at T0h,
which gives us a first indication of the AuNP action. For the
U87-MG cell line, there is also some separation along PC-1 in
Fig. 2 Micrographs of two F98 cells (top) and U87-MG cells (bottom), without (‘−NP’, left) and with (‘+NP’, right) 24 hour incubation of 500 μg
mL−1 AuNP. Bar = 10 μm. Arrows = AuNP (plain: inside cell; dotted: free AuNP).
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the score plot between the control and NP-treated cells in the
fingerprint region mainly at T0h.
The loading plots in the fingerprint region indicate that the
largest biochemical changes induced by the NP are associated
with protein modifications in the region of 1700–1500 cm−1
for both F98 and U87-MG cell lines. The vector normalized
Savitzky–Golay second derivative calculated in the averaged
absorbance spectra (Fig. 5) shows NP-induced changes in the
protein conformational structures in the amide I and amide II
bands, especially in the F98 glioma cell line. These bands are
characteristic of peptide bonds of cell peptides and proteins.
More precisely, there is a more explicit β-type secondary struc-
ture inside the NP-treated cells,34–36 which could be related to
an initial apoptotic response of the cells, since previous
studies have reported changes in the expression of pre-apopto-
tic proteins using the same type of NP.25
The separation of the NP-treated group at T24h along PC-2
also has some contribution of the asymmetric phosphodiester
band of the DNA (1238 cm−1), particularly in the case of the
F98 cell line. We observe a shift towards the low frequency
region for NP-treated cells (see Fig. 5). This shift has been
observed in our previous work using gadolinium NP.21,27 We
also observe changes in the distribution of the relative intensi-
ties of several DNA spectral bands (PhI/AII, PhII/AII), as shown
in Fig. 6 (top). At T24h, there is a slight decrease in the PhII/AII
ratio in the case of U87-MG cells, which might be correlated to
cell cycle changes and, particularly, to an increase in the sub
G1 cell population induced by these AuNP.
25 Previous studies
have reported similar changes in the DNA region of the infra-
red spectra due to cell cycle modifications.36,37 Finally, it is
important to note that we clearly observe an increase in the
variance of the DNA biochemical content in NP-treated cells
with respect to controls (−NP) both at T0h and T24h and for
both cell lines, as a result of diﬀerent NP–cell interaction
mechanisms.
In the region of 3000–2800 cm−1, mostly representative of
fatty acids encountered in the membranes, there is a separ-
ation between the scores of control cells and NP-treated cells
in F98 glioma line (Fig. 3). NP-treated cells are correlated
with peaks at 2848 cm−1 and 2915 cm−1, while control cells
are correlated with peaks at 2935 cm−1 and 2858 cm−1. This
corresponds to changes in the asymmetric and symmetric
vibrations of CH2 stretching groups.
38 Changes in these
peaks were previously related to the changes in the lipid
structure and chain length due to oxidative stress and mem-
brane peroxidation.38–41 The separation in the PCA scores
between −NP and +NP groups is less clear in the case of U87-
MG cells (Fig. 4).
Fig. 3 F98 glioma cells: biochemical eﬀects induced by the AuNP prior to irradiation (0 Gy). The PCA scores (top) and the corresponding loading
plots (bottom) are presented in the ﬁngerprint (1800–1000 cm−1; left) and lipid (3100–2800 cm−1; right) spectral regions in the presence (‘+NP’) and
absence (‘−NP’) of nanoparticles at two post-irradiation ﬁxation times (0 h and 24 h).
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The violin plots in Fig. 6 (bottom) show a clear increase in the
CH2/CH3 ratio distribution for F98 cells (both at T0h and T24h),
which might indicate evidences of oxidative stress.39,40 There are
also indications of oxidative stress in the U87-MG cells after NP-
treatment (T0h), which seems to be reduced at T24h. The induction
of AuNP-related oxidative stress has been previously reported using
the same type of NP via increased production of endogenous reac-
tive oxygen species and depletion of intracellular antioxidants.25,42
Fig. 4 U87-MG glioma cells: biochemical eﬀects induced by the AuNP prior to irradiation (0 Gy). The PCA scores (top) and the corresponding
loading plots (bottom) are presented in the ﬁngerprint (1800–1000 cm−1; left) and lipid (3100–2800 cm−1; right) spectral regions in the presence
(‘+NP’) and absence (‘−NP’) of nanoparticles at two post-irradiation ﬁxation times (0 h and 24 h).
Fig. 5 F98 (left) and U87-MG (right) glioma cells: biochemical eﬀects induced by the AuNP prior to irradiation (0 Gy). The vector normalized
Savitzky–Golay second derivative calculated in the averaged absorbance spectra is shown for the −NP and +NP controls at two post-irradiation
ﬁxation times (0 h and 24 h) in the ﬁngerprint (1800–1000 cm−1) spectral region. The insets show a zoom of the 1700–1600 cm−1 and
1350–1000 cm−1 regions.
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Our findings evidence a diﬀerent biochemical response
depending on the tumor cell model, which could be related to
a diﬀerent radiosensitization capability according to NP local-
ization, NP-cell interaction processes or degree of sensitivity to
oxidative damage or others.5,25,26 This could explain the diﬀer-
ences in NP internalization relative to the cell type shown in
the microscopy pictures (see Fig. 2) and might be related to
the subsequent variations in the biochemical eﬀects observed
by SR-FTIRM.
3.3. SR-FTIRM study on the radiosensitization eﬀects at
several radiation doses
Fig. 7 and 8 show the PCA scores and the corresponding
loading plots on second derivative spectra for both F98 and
U87-MG cell lines, respectively, and several configurations:
doses (from 5 to 20 Gy), with/without NP (−NP/+NP) and post-
irradiation times (T0h/T24h). PCA scores were separated as a
function of the dose to assess the eﬀect of AuNP for the same
irradiation conditions. The two fixation times are compared in
the same PCA scores to assess cell response to the treatments
as a function of time.
In F98 glioma cells, the protein region of the fingerprint
spectral range (1700–1500 cm−1) is the main factor respon-
sible for PCA score separation. PC1–PC2 score plots display
clearly separated clusters (−NP/NP and T0h/T24h), particularly
for 10 Gy and 20 Gy and in the case of T24h. PC-1 and PC-2
take into account around 70% and 10% of the variance,
respectively, for all doses. The loading plots show that wave-
numbers around 1628 cm−1 are highly correlated to NP-
treated groups, while wavenumbers around 1660−1 are corre-
lated to irradiated groups without AuNP. This correlation is
better manifested at T24h. While the first is attributed to the
β-sheet conformation of the amide I band, the second one is
assigned to the α-helix form.34 This indicates a shift towards
lower wavenumbers in the amide for irradiated cells in the
presence of AuNP, as can be seen in Fig. 9 (left). Previous
studies correlated this shift to an increase in disordered
structures due to protein denaturation.43 In our case, the
secondary protein structure changes inside the cells corre-
lated with protein unfolding and/or denaturation might be
related to cell death under treatment-induced stress.36,44
This stress could be enhanced by the increased generation
of ROS due to the presence of AuNP, which has been associ-
ated with changes in the amide I and II bands.44–46 An ampli-
fication in the apoptotic response of irradiated cells in the
presence of AuNP is in accordance with our previous FTIRM
study using gadolinium NP.21,27 The protein modifications as
a function of the treatment are clearly shown on the vector
normalized Savitzky–Golay second derivative plot (Fig. 9,
left).
Fig. 6 F98 (left) and U87-MG (right) glioma cells: biochemical eﬀects induced by the AuNP prior to irradiation (0 Gy). The violin plots are showing
the distribution of the relative intensities of several spectral band ratios (PhI/AII, PII/AII and CH2/CH3; see section 2.6 for more information) for the
−NP (blue) and +NP controls at two ﬁxation times (0 h, in orange; 24 h in green).
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Fig. 7 F98 glioma cells: radiosensitization eﬀects of AuNP for several doses: 5 Gy (left), 10 Gy (center) and 20 Gy (right). The PCA scores and the
corresponding loading plots are presented in the ﬁngerprint (1800–1000 cm−1; top) and lipid (3100–2800 cm−1; bottom) spectral regions.
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Fig. 8 U87-MG glioma cells: radiosensitization eﬀects of AuNP for several doses 5 Gy (left), 10 Gy (center) and 20 Gy (right). The PCA scores and
the corresponding loading plots are presented in the ﬁngerprint (1800–1000 cm−1; top) and lipid (3100–2800 cm−1; bottom) spectral regions.
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In the case of U87-MG cells, the eﬀect is less clear since the
PC1–PC2 scores in the fingerprint region show more overlap-
ping between ‘−NP’ and ‘+NP’ groups. For 20 Gy, we observe a
slight separation of the NP-treated group for both fixation
times. Loading plots mainly correlate this separation with sec-
ondary protein structure changes and modifications in the
asymmetric phosphodiester bands. These changes, amplified
in the presence of NP, are probably related to an enhanced cell
death response due to the combination of radiation damage
and AuNP-induced biochemical modifications. However, we
observed a reduced biochemical response to AuNP with
respect to F98 cells in the presence of radiation, since second-
ary structure protein changes are less clear in the Savitzky–
Golay second derivative plot (Fig. 9, right).
Fig. 10 shows the distribution of the relative intensities of
several spectral band ratios (PhI/AII, PhII/AII, AI/AII and CH2/
CH3) defined in section 2.6. For the F98 cell line, we observe a
decrease in the absorbance of the AI/AII ratio in NP-treated
cells. Changes in the amide I and amide II absorbance were
previously related to DNA repair processes, which involves
many enzymes to repair the damage produced by the ionizing
radiation.47,48 The changes in relative intensity between the
areas in amide I and amide II bands have also been correlated
with the biochemical changes of cellular proteins following
apoptosis, which aﬀects the overall protein folding and localiz-
ation and thus, the infrared absorption of peptide bonds.30,31
By looking into the DNA region (1350–1000 cm−1) in the
vector normalized Savitzky–Golay second derivative plot
(Fig. 9), which is assigned to phosphodiester groups mostly
found in nucleic acids, we observe several changes in the
intensity and position (shifts) of several peaks. This probably
implies a number of diﬀerent variations in DNA organization
or local conformation as a result of radiation damage, which is
amplified in the presence of AuNP. The investigation of the
loadings shows a slight variance emerging from the asym-
metric phosphodiester band of the DNA at 1238 cm−1 for NP-
treated groups at T24h. The diﬀerential biochemical response
to AuNP in the DNA region is more visible in the case of F98
than in the case of U87-MG cells.
For F98 glioma cells, the violin plots of Fig. 10 show a slight
reduction in the PhII/AII ratio for NP-treated cells at T24h,
which has been previously correlated with chromatin fragmen-
tation and apoptotic DNA condensation in previous
studies.28,30,49 Previous studies have reported similar vari-
ations as a result of radiation damage.31,44,47,49 Instead, U87-
MG cells exhibit a clear increase in the PhI/AII and PhII/AII
ratios at T24h in NP-treated cells. An increase in the phospho-
diester bands was already observed in the work of Lipiec and
collaborators for PC-3 (human prostate adenocarcinoma) cells
following proton irradiation.47 The increase in the intensity of
the DNA backbone was correlated with multiple DNA
breakages.47,50
When comparing NP-treated cells in the lipid region
(3100–2800 cm−1), the score plots do not display clear separ-
ated clusters, despite the fact that the NP-treated groups at
T24h seem to be slightly separated towards positive PC-1 in
both cell lines from the other groups (T0h and T24h without
AuNP). Fig. 10 shows some increase in CH2/CH3 ratio distri-
bution (defined in section 2.6) at T24h, which is more marked
for U87-MG cells. The higher absorbance in the CH2 asym-
metric stretching mode with respect to the CH3 asymmetric
stretching has been reported with cell death processes in pre-
vious studies.28 Indeed, a higher CH2/CH3 ratio has been
determined for apoptotic cells by proton nuclear magnetic
resonance spectroscopy in previous studies.51–53
Finally, it is important to remark that we observe a higher
intra-cellular variation in treated cells, demonstrating the het-
erogeneity in the biochemical cell response among the same
cell population and also among cell lines. This is probably due
to diﬀerent NP–cell interaction processes, and degree of sensi-
tivity to oxidative/radiation damage or others. The radiosensiti-
zation potential dependence as a function of the cell type has
Fig. 9 F98 (left) and U87-MG (right) glioma cells: radiosensitization eﬀects of AuNP (20 Gy). The vector normalized Savitzky–Golay second deriva-
tive calculated in the averaged absorbance spectra is shown for the −NP and +NP controls at two post-irradiation ﬁxation times (0 h and 24 h) in the
ﬁngerprint (1800–1000 cm−1) spectral region. The insets show a zoom of the 1700–1600 cm−1 and 1350–1000 cm−1 regions.
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Fig. 10 F98 (left) and U87-MG (right) glioma cells: radiosensitization eﬀects of AuNP (20 Gy). The violin plots are showing the distribution of the
relative intensities of several spectral band ratios (PhI/AII, PhII/AII, AI/AII and CH2/CH3; see section 2.6 for more information) for the ‘−NP’ (blue) and
‘+NP’ (orange) controls at two post-irradiation ﬁxation times (0 h and 24 h).
Fig. 11 Metabolic activity of F98 cells (left) and U87-MG cells (right) with and without NP for several doses of radiation. The control cell group was
considered to have 100% of living cells. The values obtained with the diﬀerent cell treatments were normalized using the values of the control cell
group. Data are presented as the mean and standard error of the mean (SEM). Statistical signiﬁcance in the analysis of the eﬀect of the radiation
dose, with or without NP, was determined using a standard two-tailed unpaired t-test. If any, non-signiﬁcant diﬀerences (ns) with p ≥ 0.05 are indi-
cated on the graphs.
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also been reported in previous studies using the same type of
NP.5,25,26,54 The distinct cellular responses of diﬀerent cell
lines are a key point for the study of radiosensitization eﬀects
of NP. Within this context, SR-FTIRM can provide new insights
into the molecular and cellular levels for understanding the
complex radiosensitization processes involving nanoparticles
and radiotherapy, as shown in this work.
3.4. Cell viability assay
Fig. 11 shows the results of the resazurin–resorufin prolifer-
ation assay performed on treated cells, with or without AuNP,
and with or without X-ray irradiations at 24 hours post-
irradiation time, to correlate with respect to the infrared data
at T24h.
F98 glioma cells seem to be more sensitive to AuNP, already
in the absence of radiation. Also, in the presence of radiation,
U87-MG cells seem to be less sensitive to AuNP compared to
F98 cells since the metabolic activity is not significantly
diﬀerent in the presence of AuNP. In F98 glioma cells, we can
observe significant changes for the lowest dose (5 Gy), since
the F98 metabolic activity is decreased in the presence of
AuNP. It is interesting to note that the macroscopical measure-
ment of the metabolic activity through the proliferation assay
does not allow the diﬀerentiation of the eﬀect of AuNP on
both cell lines in all configurations, whereas SR-FTIRM shows
more detailed events occurring at the molecular level. In this
study, the choice of performing the proliferation test at
24 hours post-irradiation was to be able to correlate with the
SR-FTIRM data and early biological events. Larger eﬀects
might be expected at larger post-irradiation times, as reported
in previous studies using the same type of NP.25
4. Conclusions
Despite significant evidence on the radiosensitization eﬀects
of AuNP, the exact mechanisms of radiosensitization are not
clear. This work constitutes the first study of the radiosensiti-
zation eﬀects of 1.9 nm AuNP in the F98 and U87-MG glioma
cell lines by synchrotron-based infrared microspectroscopy at
the single-cell scale. SR-FTIRM is a powerful tool for monitor-
ing biochemical changes induced by AuNP combined with
radiotherapy for assessing diﬀerent cell responses to the
treatments.
Cell–NP interactions diﬀer in both cell lines. Prior to
irradiation, AuNP induced spectral variations were observed
both in the fingerprint and in the lipid regions. In particular,
initial conformational changes in the protein secondary struc-
tures (F98, U87-MG), an increase in the CH2/CH3 ratio (F98
cells), and absorbance intensity variations in the phosphodie-
ster vibrations of the DNA (U87-MG) are detected. The bio-
chemical alterations induced by the AuNP on both cell lines
give us a first indication on the AuNP action.
PCA analysis reveals clear NP-induced changes when AuNP
are combined with radiotherapy. The main spectral variations
include a shift toward the low wavenumber in the protein
bands (F98), changes in amide I/II relative intensity (F98), and
relative amplitude changes in the CH2 and CH3 stretching
modes (U87-MG), along with several DNA organization or local
conformation modifications (F98, U87-MG) due to the pres-
ence of AuNP. These changes are better manifested at T24h and
they are probably related to an initial cell death response of
the cells, which is amplified in the presence of AuNP.
SR-FTIRM results showed the heterogeneity in the biochemical
cell response among diﬀerent cell lines (and among the same
cell population), probably due to the diﬀerent NP–cell inter-
action processes, degree of sensitivity to oxidative/radiation
damage, etc., which implies diﬀerent radiosensitization capa-
bilities as a function of the cell line.
Despite the fact that SR-FTIRM provides a deeper under-
standing of the NP-induced molecular and cellular response at
a biochemical level, further biological studies are required to
assess the role of diﬀerent (physical and biochemical) radio-
sensitization mechanisms as a function of NP and cell type.
Comprehensive characterization studies of cellular responses
to AuNP are required for the further development of this prom-
ising technique towards potential clinical translation.
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